Seventh European Medicines Agency - Medicines for Europe annual bilateral meeting

Guidance, Documents, Resources
1

The meeting was held on 29 May 2024. The highlight is shared on the EMA page.

An overview of a recent survey done to assess the risk of medicines shortages caused by the identification of N-nitrosamines impurities and regulatory actions taken at member state level was provided by Medicines for Europe.

Though survey results were not shared, there appears to be a certain gap in awareness regarding the nitrosamine issue between the EMA and Medicines for Europe.

1 Like
2

I want to add the presentation slides by Medicines for Europe in the past events. Some members of Medicines for Europe look to struggle in the recall of their medicines.

Presentation - Nitrosamines survey results implementation of nitrosamines guidance throughout EU MSs
(29/01/2024)

Industry presentation (2) - Fourth meeting of the Nitrosamine Implementation Oversight Group (NIOG) and pharmaceutical Industry (07/02/2023)

3 Likes